Anlon Healthcare Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

Anlon Healthcare at Rs 15.16 is a pharma and healthcare company whose share price target of Rs 18.00 for 2027 represents approximately 20 percent upside from the current market price. The Anlon Healthcare share price target rises to Rs 23.00 by 2028 and Rs 36.00 by 2030, implying a 4-year upside of approximately 137 percent from August 2026 levels. FY26 EPS of ₹0.5 growing approximately25% a year, capitalised at approximately28x forward earnings; growth tapers to approximately20% further out..

The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the Anlon Healthcare share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.

Click Here – Get Free Investment Predictions

Anlon Healthcare Company Overview

Metric	Details
NSE Ticker	AHCL
Sector	Pharma and Healthcare
CMP (06 Aug 2026)	Rs 15.16
Market Cap	Rs 806 Cr
FY26 EPS	Rs 0.5 (25% annual growth)
Anlon Healthcare Share Price Target 2027	Rs 18.00 (+20%)
Anlon Healthcare Share Price Target 2028	Rs 23.00 (+52%)
Anlon Healthcare Share Price Target 2030	Rs 36.00 (+137%)
Bull Case 2030	Rs 46
Bear Case 2030	Rs 27

What most investors miss: Multiple new molecules in validation/commercialization pipeline targeting FY27-FY28 could be a growth catalyst not yet fully priced in

FY26 EPS of ₹0. 5 growing approximately25% a year, capitalised at approximately28x forward earnings; growth tapers to approximately20% further out. The share price target of Rs 18.00 for 2027 and Rs 36.00 for 2030 reflect this earnings trajectory.

Why Is the Anlon Healthcare Share Price Target Set at Rs 18.00 for 2027

Domestic Branded Formulations Revenue Growth

This is the primary driver of the Anlon Healthcare share price target for 2027 and 2030. FY26 EPS of ₹0.5 growing approximately25% a year, capitalised at approximately28x forward earnings; growth tapers to approximately20% further out.. Investors tracking this metric quarterly will have the earliest signal of whether the Anlon Healthcare share price target timeline is on track.

Export Markets and Regulatory Compliance Track Record

The Anlon Healthcare share price target of Rs 18.00 for 2027, rising to Rs 36.00 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the Anlon Healthcare share price target thesis.

Product Pipeline and New Launch Capability

This structural factor underpins the long-term Anlon Healthcare share price target of Rs 36.00 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.

Manufacturing Scale and Cost Efficiency

For the Anlon Healthcare share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 23.00 target in 2028 when earnings quality is most clearly visible.

India's Healthcare Spending Growth Is a Structural Tailwind

India's long-term economic growth trajectory creates a secular tailwind for Anlon Healthcare's business that amplifies the company-specific earnings compounding embedded in the Anlon Healthcare share price target 2030 of Rs 36.00 (+137% from CMP Rs 15.16).

Anlon Healthcare Share Price Targets 2027, 2028 and 2030

Anlon Healthcare Share Price Target 2027: Rs 18.00

The Anlon Healthcare share price target 2027 is Rs 18.00, representing approximately 20 percent upside from CMP Rs 15.16. FY26 EPS of ₹0.5 growing approximately25% a year, capitalised at approximately28x forward earnings; growth tapers to approximately20% further out.. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the Anlon Healthcare share price target.

Anlon Healthcare Share Price Target 2028: Rs 23.00

The Anlon Healthcare share price target 2028 is Rs 23.00, implying approximately 52 percent upside from CMP. By FY29, Anlon Healthcare should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the Anlon Healthcare share price target thesis typically triggers institutional re-rating toward the Rs 23.00 level.

Anlon Healthcare Share Price Target 2030: Rs 36.00

The Anlon Healthcare share price target 2030 is Rs 36.00, implying approximately 137 percent upside from CMP and a 4-year CAGR of approximately 24 percent. By FY31, Anlon Healthcare should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.

Bull Case and Bear Case for Anlon Healthcare Share Price Target 2030

Bull Case: Rs 46

The bull case Anlon Healthcare share price target of Rs 46 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.

Bear Case: Rs 27

The bear case Anlon Healthcare share price target of Rs 27 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.

Scenario	Target 2030	Return
Bull Case	Rs 46	+203%
Base Case	Rs 36.00	+137%
Bear Case	Rs 27	+78%

Key Risks to the Anlon Healthcare Share Price Target

USFDA Compliance and Inspection Risk

Any regulatory action on Anlon Healthcare's manufacturing facilities could delay product launches and reduce the Anlon Healthcare share price target earnings.

Currency Risk on Export Revenue

INR appreciation against USD and EUR reduces the INR value of Anlon Healthcare's international revenues and the Anlon Healthcare share price target EPS.

Generic Pricing Pressure in Export Markets

Intensifying competition in US and European generic markets compresses pricing and the Anlon Healthcare share price target margin assumptions.

Clinical and Approval Timeline Risk

Delays in pipeline product approvals would push revenue ramp-up beyond the Anlon Healthcare share price target timeline.

How to Invest in Anlon Healthcare

Use the Univest Screener to track Anlon Healthcare's quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker AHCL. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the Anlon Healthcare share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.

Use the Univest Screener to Track This Stock Live

Conclusion

The Anlon Healthcare share price target of Rs 18.00 for 2027, Rs 23.00 for 2028, and Rs 36.00 for 2030 reflects analyst consensus earnings compounding in the pharma and healthcare sector. The 4-year upside of approximately 137 percent from CMP Rs 15.16 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.

Download the Univest iOS App or Univest Android App to track Anlon Healthcare share price live and get daily stock recommendations.

Frequently Asked Questions on Anlon Healthcare Share Price Target 2027 2028 and 2030

What is the Anlon Healthcare share price target for 2027?

Ans. The Anlon Healthcare share price target for 2027 is Rs 18.00, representing approximately 20 percent upside from CMP Rs 15.16 as of August 2026. Please verify all data at NSE India before investing.

What is the Anlon Healthcare share price target for 2030?

Ans. The Anlon Healthcare share price target for 2030 is Rs 36.00, implying approximately 137 percent upside from CMP Rs 15.16. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.

What is the Anlon Healthcare share price target for 2028?

Ans. The Anlon Healthcare share price target for 2028 is Rs 23.00, implying approximately 52 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.

Is Anlon Healthcare a good long-term investment?

Ans. Anlon Healthcare has a defined analyst projection for earnings compounding through FY31 in the pharma and healthcare sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.

What are the key risks to the Anlon Healthcare share price target?

Ans. Key risks include sector-specific headwinds such as usfda compliance and inspection risk, currency risk on export revenue, and broader macro slowdowns. Please review the full risks section in this article before investing.

What is the bull case for Anlon Healthcare share price by 2030?

Ans. The bull case Anlon Healthcare share price target for 2030 is Rs 46, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.

What is Anlon Healthcare's current market cap?

Ans. Anlon Healthcare has a market cap of approximately Rs 806 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.

How can I invest in Anlon Healthcare?

Ans. You can buy Anlon Healthcare shares through any SEBI-registered broker by searching for NSE ticker AHCL. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.